Part 8: Stabilization of the Patient With Acute Coronary Syndromes
暂无分享,去创建一个
[1] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[2] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[3] Y. Ohtsuki,et al. ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.
[4] D. Pahlajani,et al. Comparison of clinical outcome of fixed-dose subcutaneous low molecular weight heparin (tinzaparin) with conventional heparin in unstable angina: a pilot study. , 1997, Indian heart journal.
[5] R. Virmani,et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.
[6] R. Califf,et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.
[7] T. Meinertz,et al. Prehospital testing for troponin T in patients with suspected acute myocardial infarction. , 1999, American heart journal.
[8] R. Fitzgerald,et al. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. , 2001, The American journal of cardiology.
[9] R. Collins,et al. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.
[10] K. Coyne,et al. Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2001, Circulation.
[11] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[12] R. Collins,et al. ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials. , 1993, The American journal of cardiology.
[13] E. Vicaut,et al. Independent role of arterial O2 tension in local control of coronary blood flow. , 1990, The American journal of physiology.
[14] F Rovelli,et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. , 1998, Circulation.
[15] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[16] R. Collins,et al. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.
[17] C. Wilson,et al. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. , 2002, European heart journal.
[18] E. Braunwald,et al. Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion. , 1975, The American journal of cardiology.
[19] R. Virmani,et al. Plaque morphology in sudden coronary death. , 1998, Cardiologia.
[20] D. Moser,et al. Women's decision to seek care for symptoms of acute myocardial infarction. , 1995, Heart & lung : the journal of critical care.
[21] T. Feldman,et al. Evaluation of patients for the need of thrombolytic therapy in the prehospital setting. , 1989, Annals of emergency medicine.
[22] S. Solomon,et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. , 1997, Circulation.
[23] R. Califf,et al. Relation of Increased Arterial Blood Pressure to Mortality and Stroke in the Context of Contemporary Thrombolytic Therapy for Acute Myocardial Infarction , 1996, Annals of Internal Medicine.
[24] J. Vítovec,et al. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction. , 2000, International journal of cardiology.
[25] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. , 1995, The New England journal of medicine.
[26] J. Canto,et al. Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb/IIIa inhibitors. , 2002, The American journal of cardiology.
[27] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[28] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[29] C. Maynard,et al. Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction. , 2000, North Carolina medical journal.
[30] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[31] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[32] Paul Dorian,et al. The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. , 2004, The Canadian journal of cardiology.
[33] H. White,et al. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study☆☆☆★ , 2002 .
[34] 岡田 和夫,et al. 話題 「Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care--International Consensus on Science」の日本における普及と取り組み , 2001 .
[35] Study,et al. Oral captopril versus placebo among 14962 patients with suspected acute myocardial infarction: a multicenter,randomized,double-blind,placebo controlled clinical trial , 1997 .
[36] V. Fuster. Elucidation of the role of plaque instability and rupture in acute coronary events. , 1995, The American journal of cardiology.
[37] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[38] J. Salerno. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). , 1986, Lancet.
[39] J. Rawles. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). , 1994, Journal of the American College of Cardiology.
[40] T. Aufderheide,et al. Feasibility of prehospital r-TPA therapy in chest pain patients. , 1992, Annals of emergency medicine.
[41] B. Lilja,et al. Effects of oxygen on acute myocardial infarction: a thermographic study in the dog. , 1977, Cardiovascular research.
[42] Bridget Wilcken,et al. Pathogenesis of coronary artery disease , 1969 .
[43] G. Peirce,et al. Polarographic Oxygen, the Epicardial Electrocardiogram and Muscle Contraction in Experimental Acute Regional Ischemia of the Left Ventricle , 1958, Circulation research.
[44] Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. American College of Emergency Physicians. , 2000, Annals of emergency medicine.
[45] R. Gibbons,et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002, European heart journal.
[46] B. Brodie,et al. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction. , 1996, Journal of the American College of Cardiology.
[47] S. Egaas. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction , 1997 .
[48] R. Collins,et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. , 1988, JAMA.
[49] Harlan M Krumholz,et al. Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 Analysis , 2005, Circulation.
[50] J. Herlitz,et al. Limitation of infarct size by beta blockers and its potential role for prognosis. , 1983, Circulation.
[51] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[52] T. Aufderheide,et al. The diagnostic impact of prehospital 12-lead electrocardiography. , 1989, Annals of emergency medicine.
[53] V. Fuster,et al. Pathogenesis of thrombosis in coronary artery disease. , 1997, Haemostasis.
[54] T. Investigators,et al. A comparison of reteplase with alteplase for acute myocardial infarction , 1997 .
[55] W. Rogers,et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.
[56] Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation , 2001, Heart.
[57] D. Brieger,et al. Optimal strategy for administering enoxaparin to patients undergoing coronary angiography without angioplasty for acute coronary syndromes. , 2002, The American journal of cardiology.
[58] R. Wilcox. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence: International Joint Efficacy Comparison of Thrombolytics , 1995 .
[59] L. S. Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction , 1993, The Lancet.
[60] W. Weaver,et al. Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators. , 1996, The American journal of cardiology.
[61] K. Swedberg,et al. Göteborg Metoprolol Trial: effects on arrhythmias. , 1984, The American journal of cardiology.
[62] J. Ioannidis,et al. Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis. , 2001, Annals of emergency medicine.
[63] M. Bourassa,et al. The effects of inhalation of 100 percent oxygen on myocardial lactate metabolism in coronary heart disease. , 1969, The American journal of cardiology.
[64] Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group. , 1997, Chinese medical journal.
[65] T. Feldman,et al. Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital. , 1987, The American journal of cardiology.
[66] M. Dalby,et al. Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis , 2003, Circulation.
[67] Johan Herlitz,et al. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. , 1985, European heart journal.
[68] J. Herlitz,et al. Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome , 2003, Journal of internal medicine.
[69] Klaus Rasmussen,et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. , 2003, The New England journal of medicine.
[70] F. Fabris,et al. Heparin-induced thrombocytopenia. , 2000, Haematologica.
[71] D. Moser,et al. Women’s Early Warning Symptoms of Acute Myocardial Infarction , 2003, Circulation.
[72] E. Braunwald,et al. Reduction of Infarct Size by Oxygen Inhalation Following Acute Coronary Occlusion , 1975, Circulation.
[73] P. Kudenchuk,et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.
[74] R. Beale,et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. , 1993, JAMA.
[75] B. Magnani,et al. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction , 1995 .
[76] W. Weaver,et al. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. , 1997, Archives of internal medicine.
[77] B. Magnani,et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. , 1998, American heart journal.
[78] E. Topol. A comparison of reteplase with alteplase for acute myocardial infarction. , 1998, The New England journal of medicine.
[79] I. Ford,et al. Early treatment with captopril after acute myocardial infarction. , 1993, British heart journal.
[80] R. Gibbons,et al. Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002 .
[81] J. Gore,et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 1998, Journal of the American College of Cardiology.
[82] J. Greenfield,et al. Effect of hyperoxia on regional blood flow after coronary occlusion in awake dogs. , 1980, The American journal of physiology.
[83] Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group. , 1988, JAMA.
[84] J. Alpert,et al. Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction. A communitywide perspective. , 1994, Circulation.
[85] M. Legato. Coronary artery disease in women. , 1996, International journal of fertility and menopausal studies.
[86] E. Cook,et al. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. , 1989, The American journal of cardiology.
[87] J. W. Schaeffer,et al. ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) , 2000 .
[88] Paolo Berger,et al. Randomized, double blind comparison of reteplase double bolus administration with streptokinase in acute myocardial infarction (inject): Trial to investigate equivalence , 1996 .
[89] R. Fitzgerald,et al. Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.
[90] S. Banerjee,et al. Fast-tracking of Myocardial Infarction by Paramedics , 1998, Journal of the Royal College of Physicians of London.
[91] S. Black,et al. Alterations in Endogenous Nitric Oxide Production After Cardiopulmonary Bypass in Lambs With Normal and Increased Pulmonary Blood Flow , 2000, Circulation.
[92] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[93] Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.
[94] E. Antman,et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.
[95] F. Sheehan,et al. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. , 1988, Circulation.
[96] A. Skene,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.
[97] R. Califf,et al. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. , 1998, Circulation.
[98] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.
[99] S. Cannizzaro,et al. Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects. , 1994, International journal of cardiology.
[100] S. Clark,et al. Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.
[101] R. Kloner,et al. Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction. , 1990, European heart journal.
[102] E. Braunwald,et al. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. , 1999, American heart journal.
[103] K A Eagle,et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.
[104] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[105] S. Yusuf,et al. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial , 2004, Circulation.
[106] P. Armstrong,et al. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. , 2003, Circulation.
[107] M. Flather,et al. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. , 1995, Circulation.
[108] J S Martin,et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. , 1991, Journal of the American College of Cardiology.
[109] D. Moliterno,et al. Aspirin, ticlopidine, and clopidogrel in acute coronary syndromes: underused treatments could save thousands of lives. , 1999, Cleveland Clinic journal of medicine.
[110] Steve Goodacre,et al. How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[111] E. Antman,et al. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. , 2002, European heart journal.
[112] R. Collins,et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.
[113] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[114] J. Anderson,et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. , 1990, The American journal of cardiology.
[115] E. Braunwald,et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.
[116] M. Kayıkçıoğlu,et al. Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty. , 2002, Acta cardiologica.
[117] R. Gibbons,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. , 1998, JAMA.
[118] G. Ginsburg,et al. The evaluation of chest pain in women. , 1996, The New England journal of medicine.
[119] Early angiography and angioplasty following thrombolytic therapy of acute myocardial infarction. Metaanalysis of the randomized control trials. , 1993, The Online journal of current clinical trials.
[120] C. Y. Lu. [Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study]. , 1993, Zhonghua xin xue guan bing za zhi.
[121] S. Yusuf,et al. Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes: Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study , 2003, Circulation.
[122] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[123] M. Aschermann,et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2. , 2003, European heart journal.
[124] M. Keltai,et al. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). , 1999, European heart journal.
[125] F. Fernández‐Avilés,et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial , 2004, The Lancet.
[126] N. Powe,et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.
[127] E. Topol,et al. Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction. , 1996, Archives of internal medicine.
[128] E. Ambrosioni,et al. Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. , 2003, American heart journal.
[129] Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. , 1993, The New England journal of medicine.
[130] J. Mead,et al. Studies of coronary disease in the experimental animal. II. Polarographic determinations of local oxygen availability in the dog's left ventricle during coronary occlusion and pure oxygen breathing. , 1951, The Journal of clinical investigation.
[131] T. Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.
[132] Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. , 1998, The New England journal of medicine.
[133] T. Takano,et al. Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome. , 2001, Japanese circulation journal.
[134] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[135] L. Deckelbaum,et al. Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. , 1999, International journal of cardiology.
[136] G. Hobbs,et al. Prehospital identification of acute coronary ischemia using a troponin T rapid assay. , 1999, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[137] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[138] V. Hasselblad,et al. Interventional cardiology: abstractEfficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: A systematic overview☆ , 2004 .
[139] J S Geddes,et al. A mobile intensive-care unit in the management of myocardial infarction. , 1967, Lancet.
[140] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[141] Emergency department: rapid identification and treatment of patients with acute myocardial infarction. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. , 1994, Annals of emergency medicine.
[142] P J Scanlon,et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and , 1999, Circulation.
[143] A. Murray,et al. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. , 1981, British heart journal.
[144] D. Simons-Morton,et al. Access to Timely and Optimal Care of Patients with Acute Coronary Syndromes — Community Planning Considerations: A Report by the National Heart Attack Alert Program , 1998, Journal of Thrombosis and Thrombolysis.
[145] E. Martin,et al. Bedside troponin T testing is not useful for early out‐of‐hospital diagnosis of myocardial infarction , 1998, Acta anaesthesiologica Scandinavica.
[146] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[147] S. Goodacre,et al. Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain. , 2003, QJM : monthly journal of the Association of Physicians.
[148] E R Bates,et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.
[149] R. Califf,et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials , 2002, The Lancet.
[150] T. Killip,et al. Arterial oxygen tension in acute myocardial infarction. Serial analysis of clinical state and blood gas changes. , 1970, American Heart Journal.
[151] M. Melville,et al. The Potential Impact of Prehospital Electrocardiography and Telemetry on Time to Thrombolysis in a United Kingdom Center , 1998 .
[152] R. Zahn,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. , 2000, The New England journal of medicine.
[153] R. Luepker,et al. Reaction to a media campaign focusing on delay in acute myocardial infarction. , 1991, Heart & lung : the journal of critical care.
[154] V. Verdile,et al. E DUCATION OF P ARAMEDICS R EGARDING A SPIRIN U SE , 2000, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[155] R. Califf,et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy , 1993, The Lancet.
[156] E. Topol,et al. Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV—Acute Coronary Syndrome) Trial , 2003, Circulation.
[157] E. Antman,et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. , 2000, Circulation.
[158] S. Yusuf,et al. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.
[159] A. Connor,et al. The way I see it: House officers need formal career development , 2002 .
[160] E. Braunwald,et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.
[161] R. Califf,et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.
[162] Harry P. Selker,et al. A Tool for Judging Coronary Care Unit Admission Appropriateness, Valid for Both Real-Time and Retrospective Use: A Time-Insensitive Predictive Instrument (TIPI) for Acute Cardiac Ischemia: A Multicenter Study , 1991, Medical care.
[163] T. Aufderheide,et al. A prospective evaluation of prehospital 12-lead ECG application in chest pain patients. , 1992, Journal of electrocardiology.
[164] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[165] J. Gaspoz,et al. Time savings with prehospital thrombolysis in an urban area , 2003, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[166] N. Rehnqvist,et al. Metoprolol in acute myocardial infarction reduces ventricular arrhythmias both in the early stage and after the acute event. , 1987, International journal of cardiology.
[167] F. Spencer,et al. Low Molecular Weight Heparin and Unfractionated Heparin in the Early Pharmacologic Management of Acute Coronary Syndromes: A Meta-analysis of Randomized Clinical Trials , 2001, Journal of Thrombosis and Thrombolysis.
[168] V. Fuster,et al. The Unstable Atherosclerotic Plaque: Clinical Significance and Therapeutic Intervention , 1997, Thrombosis and Haemostasis.
[169] R. W. Brower,et al. RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator , 1985, The Lancet.
[170] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[171] D. Chamberlain,et al. Five hundred patients with myocardial infarction monitored within one hour of symptoms. , 1983, British medical journal.
[172] R. Califf,et al. Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.
[173] N. Madias,et al. Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. , 1976, Circulation.
[174] R. Welsh,et al. Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. , 2003, The American journal of cardiology.
[175] Carl J Pepine,et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.
[176] Walker,et al. Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .
[177] P. Held. Effects of nitrates on mortality in acute myocardial infarction and in heart failure. , 1992, British journal of clinical pharmacology.
[178] M. Millar-Craig,et al. Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission , 1997, Heart.
[179] K. Lee,et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.
[180] Todd Zaayer. Accuracy of computer interpreted electrocardiography in selecting patients for thrombolytic therapy , 1992 .
[181] A. Jaffe,et al. Determinants of hemodynamic compromise with severe right ventricular infarction. , 1990, Circulation.
[182] C. Granger,et al. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. , 2003, European heart journal.
[183] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[184] M. Davies,et al. Anatomic features in victims of sudden coronary death. Coronary artery pathology. , 1992, Circulation.
[185] K. Chacko. Diagnosing and managing unstable angina. , 1995, Circulation.
[186] Eorge,et al. CARDIAC-SPECIFIC TROPONIN I LEVELS TO PREDICT THE RISK OF MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES , 2000 .
[187] H. Suryapranata,et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.
[188] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.
[189] S. Yusuf,et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis , 2000, The Lancet.
[190] L. Passos,et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. , 2003, The American journal of cardiology.
[191] M. Simoons,et al. Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The Netherlands. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.
[192] E. Topol. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.
[193] M. Smyth,et al. A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography. , 1999, Journal of pharmaceutical and biomedical analysis.
[194] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[195] E. Topol. Inflammation and embolization in ischemic heart disease. , 2000, The Journal of invasive cardiology.
[196] R. Collins,et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.
[197] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[198] J P Ornato,et al. Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest Recommended Citation Public-access Defibrillation and Survival after Out-of-hospital Cardiac Arrest , 2022 .
[199] B H Rowe,et al. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes. , 2003, The Cochrane database of systematic reviews.
[200] H. Wellens,et al. Observations on Patients with Primary Ventricular Fibrillation Complicating Acute Myocardial Infarction , 1975, Circulation.
[201] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .
[202] A. Laggner,et al. Ramipril Prior to Thrombolysis Attenuates the Early Increase of PAI-1 in Patients with Acute Myocardial Infarction , 2002, Thrombosis and Haemostasis.
[203] D. Julian,et al. Sudden death in the community - The arrhythmia causing cardiac arrest and results of immediate resuscitation , 1992 .
[204] Ayah E. Johnson,et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. , 1999, JAMA.
[205] T. Aufderheide,et al. Planning, Implementation, and Process Monitoring for Prehospital 12-Lead ECG Diagnostic Programs , 1996, Prehospital and Disaster Medicine.
[206] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.
[207] B. Haynes,et al. A rural emergency medical technician with selected advanced skills. , 1999, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.
[209] Assent investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction , 2001, The Lancet.
[210] G Barbash,et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.
[211] A. Jacobs,et al. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the Thrombolysis in Myocardial Infarction [TIMI] II trial) , 1993 .
[212] J. Rawles,et al. Controlled trial of oxygen in uncomplicated myocardial infarction. , 1976, British medical journal.
[213] K. Coyne,et al. Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II) , 2002 .
[214] B. Magnani,et al. Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study , 1998 .
[215] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[216] A. Jacobs,et al. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group. , 1993, The American journal of cardiology.
[217] E. Gurfinkel,et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. , 1995, Journal of the American College of Cardiology.
[218] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[219] Deepak L. Bhatt,et al. Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes , 2001, Circulation.
[220] J. Mcmanus. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .
[221] David Schultz,et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.
[222] E. Sowton,et al. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study. , 1987, Journal of the American College of Cardiology.
[223] R. F. Kelly,et al. Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. , 1995, American heart journal.
[224] W. Rosamond,et al. Prehospital delay in patients with acute coronary heart disease: concordance between patient interviews and medical records. , 1998, American heart journal.
[225] W. Weaver,et al. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. , 1997, Journal of the American College of Cardiology.
[226] Karl Swedberg,et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.
[227] J. W. Schaeffer,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article , 2002 .
[228] C. Fry,et al. Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.
[229] R. Califf,et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. , 1997 .
[230] Mylan C. Cohen,et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. , 1997, The American journal of cardiology.
[231] B. Cason,et al. Hyperoxemic reperfusion does not increase myocardial infarct size. , 1991, American Journal of Physiology.
[232] Dwight Lemon,et al. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .
[233] S. Yusuf,et al. Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups , 2002, Circulation.
[234] H. Swan,et al. Effect of Oxygen Breathing on Pacing‐Induced Angina Pectoris and other Manifestations of Coronary Insufficiency , 1972, Circulation.
[235] Emeras Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction , 1993, The Lancet.
[236] Carl J Pepine,et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.
[237] Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group. , 1992, BMJ.
[238] P. Touboul,et al. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.
[239] W. R. Murdoch,et al. Circulatory and Metabolic Effects of Oxygen in Myocardial Infarction , 1968, British medical journal.
[240] J. Murray,et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. , 1999, Journal of the American College of Cardiology.
[241] S. Malhotra,et al. A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial). , 2001, International journal of clinical pharmacology and therapeutics.
[242] S. Silvers,et al. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting With Suspected Acute Myocardial Infarction or Unstable Angina. , 2000, Annals of emergency medicine.
[243] J. Herlitz,et al. Prognostic value of biochemical markers, 12‐lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome , 2004, Journal of internal medicine.
[244] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[245] E. Antman,et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. , 1999, Circulation.
[246] J. Rawles,et al. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). , 1997, Journal of the American College of Cardiology.
[247] A. Van der Laarse,et al. Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction. , 1990, The American journal of cardiology.
[248] M. Aschermann,et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). , 2003, The Canadian journal of cardiology.
[249] W. Weaver,et al. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. , 1996, Circulation.
[250] S. Yusuf,et al. Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes , 2003, Circulation.
[251] Jun Zhu,et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.
[252] R. Califf,et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. , 2004, JAMA.
[253] T. Hedner,et al. Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. , 1996, Heart & lung : the journal of critical care.
[254] H. White,et al. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. , 2002, American heart journal.
[255] D. Freimark,et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. , 2002, The American journal of cardiology.
[256] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[257] D. Foster,et al. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. , 1994, The American journal of emergency medicine.
[258] R. Califf,et al. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. , 1999, The American journal of cardiology.
[259] W. Gibler,et al. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. , 1992, American heart journal.
[260] M. Simoons. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial , 2001, The Lancet.
[261] B. Nallamothu,et al. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? , 2003, The American journal of cardiology.
[262] P. Armstrong,et al. Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction , 2003, Circulation.
[263] C. Vrints,et al. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. , 1999, Circulation.
[265] M. Kayıkçıoğlu,et al. The effect of statin therapy on ventricular late potentials in acute myocardial infarction. , 2003, International journal of cardiology.
[266] Salim Yusuf,et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study , 2001, The Lancet.
[267] K. Fox,et al. Chest pain in women: clinical, investigative, and prognostic features , 1994, BMJ.
[268] M. Feldman,et al. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. , 1999, The American journal of cardiology.
[269] Daniel B. Mark,et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. , 1994, Circulation.
[270] F. Werf. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial , 1999, The Lancet.
[271] E. Topol. Thrombolytic or Angioplasty Therapy of Evolving Myocardial Infarction? , 1998, Journal of Thrombosis and Thrombolysis.
[272] W. Rogers,et al. Consultation before thrombolytic therapy in acute myocardial infarction. Second National Registry of Myocardial Infarction (NRMI 2) Investigators. , 1999, The American journal of cardiology.
[273] P. Libby,et al. High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study , 2003, Circulation.
[274] M. Olschewski,et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. , 1993, The New England journal of medicine.
[275] R. Wilcox,et al. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence International Joint Efficacy Comparison of Thrombolytics , 1995, The Lancet.
[276] S. Kelsey,et al. Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. , 1984, The American journal of cardiology.
[277] R. Virmani,et al. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. , 1995, Circulation.
[278] Aims Trial Study Group. EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.